Login / Signup

Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Miklos AcsMichael GerkenIvana GajicMax MayrJozef ZustinPompiliu Piso
Published in: Langenbeck's archives of surgery (2022)
In well-selected patients with DMPM, prolonged survival is achievable with CRS and HIPEC in specialized centers.
Keyphrases
  • minimally invasive
  • coronary artery bypass
  • palliative care
  • low grade
  • locally advanced
  • combination therapy
  • coronary artery disease
  • acute coronary syndrome
  • rectal cancer
  • high grade
  • smoking cessation